Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC

SIMPLE SUMMARY: Signal transducer and activator of transcription 3 (STAT3) plays a critical role in the development and progression of non-small cell lung cancer (NSCLC) tumors. Several reports suggest that STAT3 is involved in immunosuppression and the promotion of resistance to immune checkpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Papavassiliou, Kostas A., Marinos, Georgios, Papavassiliou, Athanasios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857288/
https://www.ncbi.nlm.nih.gov/pubmed/36672335
http://dx.doi.org/10.3390/cancers15020386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857288/
https://www.ncbi.nlm.nih.gov/pubmed/36672335
http://dx.doi.org/10.3390/cancers15020386

Ejemplares similares